Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
Baxter
McKesson
Federal Trade Commission
AstraZeneca
Cipla
McKinsey
Mallinckrodt

Generated: April 20, 2018

DrugPatentWatch Database Preview

PHENERGAN VC W/ CODEINE Drug Profile

« Back to Dashboard

Which patents cover Phenergan Vc W/ Codeine, and what generic alternatives are available?

Phenergan Vc W/ Codeine is a drug marketed by Ani Pharms and is included in one NDA.

The generic ingredient in PHENERGAN VC W/ CODEINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
Drug patent expirations by year for PHENERGAN VC W/ CODEINE
Synonyms for PHENERGAN VC W/ CODEINE
956596-12-6
Codeine / Phenylephrine / Promethazine
Codeine mixture with Phenylephrine and Promethazine
PHERAZINE VC W/ CODEINE
Prometh Hydrochloride, Phenylephrine Hydrochloride w/Codeine Phosphate
PROMETH VC W/ CODEINE
Promethazine Hydrochloride, Phenylephrine Hydrochloride w/Codeine Phosphate
PROMETHAZINE VC W/ CODEINE
SCHEMBL2524832

US Patents and Regulatory Information for PHENERGAN VC W/ CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms PHENERGAN VC W/ CODEINE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 008306-005 Apr 2, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
US Army
Chubb
Johnson and Johnson
Cipla
Dow
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.